PMID: 9643532Jun 27, 1998Paper

Severe hypercalcaemia and extensive osteolytic lesions in an adult patient with T cell acute lymphoblastic leukaemia

Medical Oncology
P AntunovicV Jelusic

Abstract

Hypercalcaemia is a rare feature of acute lymphoblastic leukaemia (ALL) in adults, particularly of the T cell type. We report on a 24-year-old patient with T-ALL, who presented with symptoms of hypercalcaemia (vomitus, acute renal failure), bone pain, extensive osteolytic lesions and normal white cell count without circulating blasts. An increased serum tumor necrosis factor (TNF-alpha) concentration of 35 pg/ml was found; it remained elevated at 52 pg/ml four weeks later, after having achieved haematological remission. Serum concentrations of IL-1beta, IL-6 and IL-2 were within the control range. The pathophysiology of hypercalcaemia in malignancy and possible mediators of bone resorption, in particular TNF-alpha, are discussed.

References

Apr 1, 1979·The Journal of Pediatrics·N K RamsayS Krutzik
Dec 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·T A LinkhartD D Strong
Jan 1, 1990·Calcified Tissue International·G R Mundy
Oct 1, 1986·Journal of Clinical Pathology·M A LaffanD Catovsky
Dec 1, 1988·British Journal of Haematology·A Stein, B J Boughton
Jan 1, 1985·Clinical and Laboratory Haematology·M W MoncrieffL E Shepherd
Sep 1, 1966·The American Journal of Medicine·G W Jordan
Jul 1, 1995·British Journal of Haematology·R BatailleM Basle
Jun 27, 1996·The New England Journal of Medicine·F Bazzoni, B Beutler

❮ Previous
Next ❯

Citations

May 22, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A J TookmanP J Lodge
May 2, 2002·Clinical Imaging·Atul MarwahArun Malhotra
Oct 9, 2019·Journal of Medical Case Reports·Mickael EssoumaGloria E Ashuntantang
Apr 24, 2018·Biological Trace Element Research·Hasan Imran AfridiFarah Naz Talpur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.